Feature | Lalitha Ramanna, M.D., FACNM
The introduction of hybrid technology — positron emission tomography/computed tomography (PET/CT) and single-photon emission computed tomography (SPECT)/CT -— has revolutionized the imaging world. This technology allows the combination of the exquisite anatomic details provided, for example, by CT, with the important and much needed functional, physiologic or metabolic information provided by molecular imaging.
November 20, 2012
News
New endovascular grafting techniques to repair tissue following abdominal aortic aneurysm rupture are generating growing enthusiasm among vascular surgeons, and a number of those new treatment options were presented at the 39th VEITHsymposium held in New York City Nov. 14 to 18.
November 19, 2012
Technology
Stryker announced the global commercial launch of the new Trevo ProVue Retriever. The Trevo ProVue Retriever is the first clot removal device fully visible during the procedure for precise positioning within the clot and optimized clot retrieval in patients experiencing acute ischemic stroke. Previous technology only provided visibility to the edges of the device.
November 19, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024Technology
Nov. 15, 2012 (GLOBE NEWSWIRE) -- Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, will unveil a national mobile and internet platform for consumers and demonstrate how enterprise imaging solutions support achieving Meaningful Use objectives at the Radiological Society of North America (RSNA) in booth #4845.
November 19, 2012
Technology
The U.S. Food and Drug Administration (FDA) has granted market clearance for the Avinger Inc. Ocelot optical coherenace tomography (OCT) catheter to help cross chronic total occlusions (CTOs) in patients with peripheral artery disease (PAD).
November 16, 2012
News
The U.S. Court of Appeals for the Federal Circuit affirmed an April 2010 federal jury decision that Medtronic CoreValve LLC is willfully infringing Edwards Lifesciences' U.S. Andersen transcatheter heart valve patent. The Appeals Court also ordered the trial court to reconsider Edwards' request for a permanent injunction that would prohibit the manufacture and sale of the CoreValve System in the United States.
November 16, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
The U.S. Patent and Trademark Office has awarded Biomedical Systems U.S. Patent Number 8301236 for its TruVue Wireless Ambulatory ECG Monitoring System. Biomedical Systems developed TruVue for the diagnosis and management of atrial fibrillation, considered the leading preventable cause of stroke affecting nearly three million Americans at a cost of $26 billion each year. The Centers for Disease Control and Prevention estimates the number of people impacted by atrial fibrillation to grow five times the current rate by 2050.
November 15, 2012
Technology
The U.S. Food and Drug Administration (FDA) granted market clearance for Cook Medical’s Zilver PTX drug-eluting peripheral stent. It is the first device of its kind on several fronts to go before FDA review. It is the first drug-eluting stent (DES) for peripheral leg vessels, the first self-expanding DES and the first DES that does not use a polymer to load and elute its drug.
November 15, 2012
Technology
November 14, 2012 — Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Valiant Captivia stent graft system for the endovascular repair of isolated lesions (excluding dissections) of the descending segment of the thoracic aorta.
November 14, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
November 14, 2012 — Vital Images received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for 3-D viewing through its universal viewer, VitreaView. The company also released tablet viewing capabilities for VitreaView.
November 14, 2012
News
Magnetic resonance imaging (MRI) is more effective than electrocardiography (ECG) at identifying "silent" heart attacks, also known as unrecognized myocardial infarctions, according to a study performed by National Institutes of Health researchers and international colleagues.
November 14, 2012News
November 14, 2012 — Two years after the joint launch of Optima MR360 and Brivo MR355, GE Healthcare announced a major milestone with the 500th shipment of these products combined, making the duo one of the fastest in GE MR (magnetic resonance) history to reach this milestone. This GE exclusive combines the speed and high resolution of an ultra-high field system with the breadth of imaging capabilities that increase the versatility of the system.
November 14, 2012Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023Feature
November 12, 2012 — Abiomed Inc. said it received an investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for the use of the new Impella RP (right-side percutaneous) in a pivotal clinical study in the United States.
November 12, 2012
Feature
November 12, 2012 — Boston Scientific Corp. and the University of Rochester Medical Center presented positive results from the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) clinical trial that demonstrated improved programming of Boston Scientific dual-chamber implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) heart devices can reduce inappropriate therapy and risk of death.
November 12, 2012
Technology
November 12, 2012 — Intrinsic Medical Imaging (IMI) introduced its Matrix Volumetric Analytics software for advanced anatomical interrogation at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) conference held Oct. 23 to 26 in Miami. The technology enables assessment of vascular and heart structure pre- and post-surgery for a wide variety of procedures.
November 12, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now